Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q1 2022 vs. Q4 2021
How the institutions holding Alterity Therapeutics Ltd changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 11 | 13 | +2 |
| Shares | 752.7K | 780.7K | +28.0K (+3.7%) |
| Value | $541.0K | $643.0K | +$102.0K (+18.9%) |
New holders (3)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 23,576 | $19.0K | 0.00% |
| Virtu Financial LLC | 19,590 | $16.0K | 0.00% |
| TCWP LLC | 7,750 | $6.00K | 0.00% |
Sold out (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| CoreCap Advisors, LLC | 216 | $1.00K |